Clinical Trial Update: Sodium Pyruvate Therapy in COPD Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of sodium pyruvate therapy for chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Sodium pyruvate (sodium pyruvate)

Snippet

Sponsor: Emphycorp | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED